<DOC>
	<DOCNO>NCT01657474</DOCNO>
	<brief_summary>The purpose study determine whether weekly application EpiFix human amniotic membrane effective biweekly application ( every two week ) treatment diabetic foot ulcer .</brief_summary>
	<brief_title>Comparative Study Two Application Regimens Amniotic Membrane Wound Graft In Management Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Male female age 18 old 2 . Informed consent must obtain 3 . Patient 's ulcer must diabetic origin large 1cm2 . Debridement do prior randomization . Subject 's informed consent participate study , must obtain prior proceed sharp debridement . 4 . Patients Type 1 Type 2 diabetes ( criterion diagnosis diabetes mellitus per ADA ) . 5 . Ulcer must present minimum four week enrollment/randomization , documented failure prior treatment heal wound . A two week run period precede enrollment/randomization trial document indolent nature wound select 6 . Additional wound may present within 3cm study wind 7 . Wound must present anatomically plantar surface foot 8 . Patient 's ulcer must exhibit clinical sign infection . 9 . Patient legal consenting age . 10 . Patient willing provide inform consent willing participate procedure follow evaluation necessary complete study . 11 . Serum Creatine less 3.0mg/dl 12 . HbA1c le 12 % 13 . Patient adequate circulation affect extremity , demonstrate one follow within past 60 day : Dorsum transcutaneous oxygen test ( TcPO2 ) result ≥30mmHg , OR ABIs result ≥0.7 ≤1.2 , OR Doppler arterial waveform , triphasic biphasic ankle affect leg 1 . Patients present ulcer probe bone ( UT Grade IIIAD ) . A positive probetobone confirm bone joint felt sterile , ophthalmological probe . 2 . Patients whose index diabetic foot ulcer great 25cm2 . 3 . Patients consider reasonable metabolic control , confirm HbA1c great 12 % within previous 90 day , 4 . Patients whose serum creatinine level 3.0mg/dl great . 5 . Patients known history poor compliance medical treatment . 6 . Patients previously randomize study , presently participate another clinical trial 7 . Patients currently receive radiation therapy chemotherapy . 8 . Patients know suspected local skin malignancy index diabetic ulcer . 9 . Patients diagnose autoimmune connective tissue disease . 10 . Nonrevascularizable surgical site 11 . Active infection site 12 . Any pathology would limit blood supply compromise healing ; 13 . Patients receive biomedical topical growth factor wound within previous 30 day 14 . Patient pregnant breast feed 15 . Patient take medication consider immune system modulator could affect graft incorporation . 16 . Allergy Gentamycin Streptomycin 17 . Wounds great one year duration without intermittent heal 18 . Wound improve great 20 % first two week trial use standard care dress Cam Boot</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>